HYDRODOXX 500 MG/G POWDER FOR USE IN DRINKING WATER FOR CHICKENS AND PIGS.
Valsts: Īrija
Valoda: angļu
Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)
Produkta apraksts
(SPC)
31-01-2015
Daži šī produkta dokumenti pašlaik nav pieejami. Varat nosūtīt pieprasījumu mūsu klientu apkalpošanas dienestam, un mēs jums paziņosim, tiklīdz mēs tos varēsim iegūt.
Nosūtīt pieprasījumu.
Nosūtīt pieprasījumu.
Aktīvā sastāvdaļa:
DOXYCYCLINE HYCLATE
Pieejams no:
Huvepharma NV
ATĶ kods:
QJ01AA02
SNN (starptautisko nepatentēto nosaukumu):
DOXYCYCLINE HYCLATE
Deva:
500 mg/g
Zāļu forma:
Powder for Oral Solution
Receptes veids:
POM
Ārstniecības grupa:
Fowl - Chicken, Porcine
Ārstniecības joma:
Doxycycline
Ārstēšanas norādes:
Antibacterial
Autorizācija statuss:
Authorised
Autorizācija datums:
2009-05-15
Produkta apraksts
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
HydroDoxx 500 mg/g Powder for use in drinking water for chickens and pigs.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
One gram contains:
Active substance:
Doxycycline (as doxycycline hyclate)
500 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Powder for use in drinking water.
Yellow powder.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Chickens (broilers)
Pigs (Fattening pigs)
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Chickens (broilers) : Prevention and treatment of Chronic Respiratory Disease (CRD) caused by _Mycoplasma_
_gallisepticum _susceptible to doxycycline.
Fattening pigs: prevention and treatment of clinical respiratory infection caused by strains of _Pasteurella multocida_
susceptible to doxycycline.
Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not
possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the
target bacteria.
The presence of the clinical disease in the herd should be established before preventive treatment is started.
4.3 CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substance, to other tetracyclines or to any excipient. Do not use in
animals with hepatic disorders.
Do not use in animals with renal disorders
See section 4.7.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
The uptake of medication by animals can be altered as a consequence of illness. In case of insufficient uptake of
drinking water, animals should be treated parenterally.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 16/01/201
Izlasiet visu dokumentu
